Guardant Health

Yahoo Finance • 3 days ago

Propel Software Accelerates Adoption of Agentic AI for PLM, QMS & PIM with Early Customers Using Live Data

Technology, Medical Device, and Consumer Goods Companies Achieve Business Efficiencies with Propel One Agentic AI Solution REDWOOD CITY, Calif., October 09, 2025--(BUSINESS WIRE)--Propel, creator of the first product value management (PVM... Full story

Yahoo Finance • 12 days ago

GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex

Company Logo The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidence, advances in genomics technology, inc... Full story

Yahoo Finance • 12 days ago

Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Guardant Health, Inc. is one of them. Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, specializes in blood-based cancer dia... Full story

Yahoo Finance • 13 days ago

Why Guardant Health (GH) Stock Is Trading Up Today

What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion diagnostic for Eli Lilly... Full story

Yahoo Finance • 13 days ago

Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic

[Cancer cells vis] koto_feja Guardant Health (NASDAQ:GH [https://seekingalpha.com/symbol/GH]) has received approval from the U.S. FDA for its Guardant360 CDx, which serves as a companion diagnostic tool. The Guardant360 CDx is specifical... Full story

Yahoo Finance • 14 days ago

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer

This marks the second FDA-approved indication for Guardant360 CDx as a companion diagnostic in breast cancer treatment ESR1 mutations are present in 40% of HR+, HER2- advanced breast cancers PALO ALTO, Calif., September 29, 2025--(BUSINES... Full story

Yahoo Finance • 20 days ago

Humana initiated, Paycom upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD Cowen upgraded Paycom (PAYC) to Buy... Full story

Yahoo Finance • 23 days ago

Catalyst Watch: Eyes on housing names, Costco earnings, global PMI reports and key M&A votes

[World Trade Center and Oculus in Lower Manhattan, NYC] AndresGarciaM/iStock Editorial via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the e... Full story

Yahoo Finance • last month

Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States

Strategic partnership will expand Shield to PathGroup’s 15,000+ primary care and OBGYN physicians PathGroup’s extensive network of phlebotomists and Patient Service Centers enables easier access to Shield, the more pleasant and convenient... Full story

Yahoo Finance • last month

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Guardant Health stock took a tumble Thursday after the company's second-generation colon cancer test lagged expectations in a pivotal study. Continue Reading View Comments... Full story

Yahoo Finance • last month

Guardant drops after data for Shield colorectal cancer screening test

[CAR T cell therapy in Colon, Colorectal cancer (<a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a>) - closeup view 3d illustration] Nemes Laszlo/iStock via Getty Images * Guardant Health (NAS... Full story

Yahoo Finance • last month

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

Company Logo Liquid Biopsy MarketLiquid Biopsy Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Applic... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK shifts focus, buys CRSP stock, sells ROKU

Cathie Wood’s ARK ETF released their daily trades for Monday, August 25th, 2025, revealing a significant reshuffle in their portfolio. The firm’s largest transaction involved selling 141,194 shares of Roku Inc (NASDAQ:ROKU), amounting to a... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK sells Shopify, Coinbase stock; buys PagerDuty

Cathie Wood’s ARK ETFs conducted a series of trades on Friday, August 22, 2025, with the most significant transactions involving the sale of Shopify Inc (NYSE:NASDAQ:SHOP) and Coinbase Global Inc (NASDAQ:COIN) shares, and the purchase... Full story

Yahoo Finance • 2 months ago

Guardant Health stock hits 52-week high at 60.69 USD

Guardant Health Inc. (NASDAQ:GH) stock reached a 52-week high of $60.69, marking a significant milestone for the $7.55 billion market cap company. According to InvestingPro analysis, the stock appears slightly overvalued at current levels... Full story

Yahoo Finance • 2 months ago

Guardant Health stock reaches 52-week high at 59.25 USD

Guardant Health Inc. stock reached a new 52-week high, closing at 59.25 USD. According to InvestingPro data, technical indicators suggest the stock is in overbought territory, with the company now commanding a market capitalization of $7.3... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK buys Archer Aviation, sells Kratos Defense stock

Cathie Wood’s ARK ETFs have made notable moves in the market on Tuesday, 12 August 2025, with a series of buys and sells that signal the investment firm’s strategic adjustments. The most significant transaction of the day involved the sale... Full story

Yahoo Finance • 2 months ago

Gamehost GAAP EPS of C$0.51, revenue of C$41.99M

* Gamehost Inc. press release [https://seekingalpha.com/pr/20198786-gamehost-announces-second-quarter-financial-results-and-dividend-for-august] (TSX:GH:CA [https://seekingalpha.com/symbol/GH:CA]): 1H GAAP EPS of C$0.51. * Revenue of C... Full story

Yahoo Finance • 2 months ago

Psychedelic Drugs Market Size to Surpass USD 10.11 Billion by 2032, Fueled by Breakthrough Therapies and Expanding Mental Health Applications – SNS Insider

Austin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Psychedelic Drugs Market Size & Growth Outlook According to SNS Insider, the global Psychedelic Drugs Market was valued at USD 3.63 billion in 2024 and is projected to reach USD 10.11 billion by... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK makes major moves in Trade Desk and Block stock

Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story